General
US FDA authorises Moderna’s COVID-19 vaccine for emergency use
Moderna’s coronavirus vaccine has become the second to receive emergency-use authorisation from the US Food and Drug Administration (FDA).
The decision provides some welcome news for a nation with a COVID-19 death toll of more than 307,000.
The FDA announced the authorisation on Friday (local time) after the agency’s panel of outside experts endorsed its use on Thursday.
The decision marks the first regulatory authorisation in the world for Moderna’s vaccine and validation of its messenger RNA technology, less than a year after the first COVID-19 case was identified in the United States.
The biotech company has worked with the US Government to prepare for the distribution of 5.9 million shots as early as this weekend.
More to come.
Reuters
-
Business23 hours ago3 of the best ASX stocks to buy now with $2,500
-
General17 hours agoActivism under the guise of good intentions
-
Noosa News16 hours agoHow errors, penalties and bad decisions helped New South Wales beat themselves in Origin II
-
Business9 hours agoWhy this speculative ASX stock could rise 100%+